A Clinical Decision Support Platform for the Risk Stratification, Diagnosis, and Prediction of Coronary Artery Disease Evolution

Annu Int Conf IEEE Eng Med Biol Soc. 2018 Jul;2018:4556-4559. doi: 10.1109/EMBC.2018.8513131.


SMARTool aims to perform accurate risk stratification of coronary artery disease patients as well as to provide early diagnosis and prediction of disease progression. This is achieved by the acquisition of data from about 263 patients including computed tomography angiographic images, clinical, molecular, biohumoral, exposome, inflammatory and omics data. Data are collected in two time points with a followup period of approximately 5 years. In the first step, data mining techniques are implemented for the estimation of risk stratification. In the next step, patients, who are classified as medium to high risk are considered for coronary imaging and computational modelling of blood flow, plaque growth and stenosis severity assessment. Additionally, patients with increased stenosis are selected for stent deployment. All the above modules are integrated in a cloud-based platform for the clinical decision support (CDSS) of patients with coronary artery disease. The work presents preliminary results employing the SMARTool dataset as well as the concept and architecture of the under development platform.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Computer Simulation
  • Coronary Angiography
  • Coronary Artery Disease / diagnosis*
  • Coronary Stenosis / diagnosis
  • Data Mining
  • Decision Support Systems, Clinical*
  • Humans
  • Models, Cardiovascular*
  • Predictive Value of Tests
  • Risk Assessment
  • Stents